Skip to main content

Articles

Page 4 of 12

  1. To evaluate the potential benefits of the Magnetic Resonance-guided high intensity Focused Ultrasound (MRgFUS) introduction in the clinical practice, for the treatment of uterine fibroids, in comparison with t...

    Authors: L. Ferrario, E. Garagiola, C. Gerardi, G. Bellavia, S. Colombo, C. Ticca, C. Rossetti, M. Ciboldi, M. Meroni, A. Vanzulli, A. Rampoldi, T. Bignardi, F. Arrigoni, E. Porazzi and E. Foglia
    Citation: Health Economics Review 2022 12:21
  2. Cancer is one of the diseases with the highest incidence and mortality in the world, and one that requires greater care (formal and informal). At present, the traditional informal caregiver is disappearing. Th...

    Authors: Raúl del Pozo-Rubio and Marta Ortega-Ortega
    Citation: Health Economics Review 2022 12:20
  3. HIV/AIDS remains the leading cause of death in sub-Saharan Africa. Due to multiple constraints experienced by households that seem to be disproportionally affected, families generally seek assistance from the ...

    Authors: Wilfried Guets, Edward Kwabena Ameyaw and Sanni Yaya
    Citation: Health Economics Review 2022 12:18
  4. Strokes cause an estimated annual health care burden of 170 billion euros across Europe. Atrial fibrillation is one of the major risk factors for stroke and increases the individual risk 4.2-fold. But preventi...

    Authors: Steffen Wahler, Ralf Birkemeyer, Dimitrios Alexopoulos, Zbigniew Siudak, Alfred Müller and Johann-Matthias von der Schulenburg
    Citation: Health Economics Review 2022 12:17
  5. Antigen-based rapid diagnostic tests (Ag-RDT) have been implemented in hospitals and nursing homes to screen for infectious individuals without symptoms suggestive of SARS-CoV-2 infections and to prevent entry...

    Authors: Alfonso Valenzuela Hurtado, Hoa Thi Nguyen, Viktoria Schenkel, Jonas Wachinger, Joachim Seybold, Claudia M. Denkinger and Manuela De Allegri
    Citation: Health Economics Review 2022 12:15
  6. This study aims at analyzing the efficiency of the health systems of 31 European countries in treating COVID-19, for the period January 1, 2020 – January 1, 2021, by incorporating some factors from a multidime...

    Authors: Dan Lupu and Ramona Tiganasu
    Citation: Health Economics Review 2022 12:14
  7. Despite the focus of the National Health Insurance Scheme (NHIS) to bridge healthcare utilisation gap among women in Ghana, recent evidence indicates that most maternal deaths still occur from rural Ghana. The...

    Authors: Raymond Elikplim Kofinti, Emmanuel Ekow Asmah and Edward Kwabena Ameyaw
    Citation: Health Economics Review 2022 12:13
  8. To assess the economic impact of powered stapler use in video-assisted thoracic surgery (VATS) lobectomy for lung cancer in a Chinese tertiary care hospital.

    Authors: Yang Cao, Fang Xiong, Xiaozhe Xia, Pengjuan Gu, Qinghong Wang, Aiping Wu, Huan Zhan, Wendong Chen and Zhaoxin Qian
    Citation: Health Economics Review 2022 12:12
  9. Public providers in Jordan are facing increasing health demands due to human crises. This study aimed to benchmark the unit costs of hospital services in public providers in Jordan to provide insights into the...

    Authors: Eman A. Hammad, Ibrahim Alabbadi, Fardos Taissir, Malek Hajjwi, Nathir M. Obeidat, Qais Alefan and Rimal Mousa
    Citation: Health Economics Review 2022 12:11
  10. Achieving universal health coverage (UHC) is a global priority and a keystone element of the 2030 Sustainable Development Goals. However, COVID-19 is causing serious impacts on tax revenue and many countries a...

    Authors: Robert John Kolesar, Peter Bogetoft, Vanara Chea, Guido Erreygers and Sambo Pheakdey
    Citation: Health Economics Review 2022 12:10
  11. Optimizing efficiency has become increasingly critical with the growing demand for finite healthcare resources driven by population growth and an ageing society. Hence, policymakers are urgently finding more e...

    Authors: Asrul Akmal Shafie, Noor Syahireen Mohammed, Kok Fong See, Hishamshah Mohd Ibrahim, Jacqueline Hui Yi Wong and Irwinder Kaur Chhabra
    Citation: Health Economics Review 2022 12:9
  12. Until recently, adjuvant treatment options for higher stage resectable cutaneous melanoma were limited. Two studies with a similar set-up, published 2017, led to registration of targeted therapy for BRAF-mutat...

    Authors: Steffen Wahler, Alfred Müller, Sabine Fuchs and Johann-Matthias von der Schulenburg
    Citation: Health Economics Review 2022 12:8
  13. The novel coronavirus is part of a series of infectious disease outbreaks that include: Ebola, Avian influenza, Middle East respiratory syndrome coronavirus, and Influenza A. This paper addresses the question ...

    Authors: Chrys Esseau-Thomas, Omar Galarraga and Sherif Khalifa
    Citation: Health Economics Review 2022 12:7
  14. Japan is one of the Organization for Economic Co-operation and Development (OECD) countries where population aging and increasing health care expenditures (HCE) are urgent issues. Recent studies have identifie...

    Authors: Yuji Hiramatsu, Hiroo Ide, Atsuko Tsuchiya and Yuji Furui
    Citation: Health Economics Review 2022 12:6
  15. Ensuring access to health services for all is the main goal of universal health coverage (UHC) plan. Out-of-pocket (OOP) payment still remains the main source of funding for healthcare in Bangladesh. The assoc...

    Authors: Md. Mizanur Rahman, Md. Rashedul Islam, Md. Shafiur Rahman, Fahima Hossain, Ashraful Alam, Md. Obaidur Rahman, Jenny Jung and Shamima Akter
    Citation: Health Economics Review 2022 12:5
  16. Although endovascular therapy (EVT) improves clinical outcomes in patients with acute ischemic stroke, the time of EVT initiation significantly influences clinical outcomes and healthcare costs. This study eva...

    Authors: Weiyi Ni, Wolfgang G. Kunz, Mayank Goyal, Lijin Chen and Yawen Jiang
    Citation: Health Economics Review 2022 12:4
  17. Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on societies. This study aimed to determine the economic burden of MS on patients using the first (CinnoVex a...

    Authors: Mehdi Rezaee, Khosro Keshavarz, Sadegh Izadi, Abdosaleh Jafari and Ramin Ravangard
    Citation: Health Economics Review 2022 12:2
  18. Tracking general trends in strategic purchasing of health financing mechanisms will highlight where country demands may exist for technical support and where progress in being made that offer opportunities for...

    Authors: Chinyere Mbachu, Chinyere Okeke, Chinonso Obayi, Agnes Gatome-Munyua, Nkechi Olalere, Ikechi Ogbonna, Benjamin Uzochukwu and Obinna Onwujekwe
    Citation: Health Economics Review 2021 11:47
  19. To estimate the out-of-pocket expenditures linked to Road Traffic Injuries in Ouagadougou, Burkina Faso, as well as the prevalence of catastrophic expenditures among those out-of-pocket payments, and to identi...

    Authors: Laurène Petitfour, Emmanuel Bonnet, Isadora Mathevet, Aude Nikiema and Valéry Ridde
    Citation: Health Economics Review 2021 11:46
  20. The aim was to determine the direct impact of the COVID-19 pandemic on Spain’s health budget.

    Authors: F. J. Carrera-Hueso, L. Álvarez-Arroyo, J. E. Poquet-Jornet, P. Vázquez-Ferreiro, R. Martínez-Gonzalbez, D. El-Qutob, M. A. Ramón-Barrios, F. Martínez-Martínez, J. L. Poveda-Andrés and C. Crespo-Palomo
    Citation: Health Economics Review 2021 11:43
  21. Vaborem is a fixed dose combination of vaborbactam and meropenem with potent activity against target Carbapenem-resistant Enterobacterales (CRE) pathogens, optimally developed for Klebsiella pneumoniae carbapenem...

    Authors: Francesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, Francesca Fiorentino, Paola La Malfa, Duccio Urbinati and Massimo Andreoni
    Citation: Health Economics Review 2021 11:42
  22. High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric ca...

    Authors: Jefferson Antonio Buendía, Ranniery Acuña-Cordero and Carlos E. Rodriguez-Martinez
    Citation: Health Economics Review 2021 11:41
  23. During the COVID-19 pandemic, health care systems are under extreme pressure. This study analyzed health care resource use (HCRU) and costs in patients admitted to the hospital for COVID-19 and aimed to estima...

    Authors: Ergun Oksuz, Simten Malhan, Mustafa Sait Gonen, Zekayi Kutlubay, Yilmaz Keskindemirci and Fehmi Tabak
    Citation: Health Economics Review 2021 11:39
  24. Economic research on hospital palliative care faces major challenges. Observational studies using routine data encounter difficulties because treatment timing is not under investigator control and unobserved p...

    Authors: Peter May, Charles Normand, Danielle Noreika, Nevena Skoro and J. Brian Cassel
    Citation: Health Economics Review 2021 11:38
  25. Nearly 19 million people across OECD countries are living with dementia, and millions of family caregivers are affected by the disease. The costs of informal care are estimated to represent 40–75% of the total...

    Authors: Renira C. Angeles, Line I. Berge, Marie H. Gedde, Egil Kjerstad, Maarja Vislapuu, Nathalie G. Puaschitz and Bettina S. Husebo
    Citation: Health Economics Review 2021 11:37
  26. Demand-side barriers to health care are as important as supply-side factors in deterring patients from obtaining effective treatment during COVID-19. Developing countries, including Togo, have focused on reduc...

    Authors: Yaovi Tossou
    Citation: Health Economics Review 2021 11:36
  27. In the absence of electronic health records, analysis of direct healthcare costs often relies on resource utilisation data collected from patient-reported surveys. This scoping review explored the availability...

    Authors: Samira B. Jabakhanji, Jan Sorensen, Gintare Valentelyte, Lee Ann Burke, Brendan McElroy and Aileen Murphy
    Citation: Health Economics Review 2021 11:35
  28. Provision of up-to-date cost information is crucial for not only addressing knowledge gap on the cost of essential health services (EHS) but also budgeting, allocating adequate resources and improving institut...

    Authors: Diriba Feyisa, Kiddus Yitbarek and Teferi Daba
    Citation: Health Economics Review 2021 11:34
  29. Breast cancer (BC) is largely prevalent worldwide. HER2-positive BC account for roughly 20–25% of all BC cases and has an overall survival lower than other BC. Innovation on BC therapeutics is a constant, but ...

    Authors: Andreia Borges, Filipa Pereira, Patrícia Redondo, Luís Antunes, Cláudia Vieira, Pedro Antunes, Maria José Bento, Susana Sousa, José Machado Lopes, Francisco Rocha-Gonçalves, Joaquim Abreu de Sousa, Deolinda Sousa Pereira and Marina Borges
    Citation: Health Economics Review 2021 11:33
  30. Antibiotics have been overprescribed to treat infectious diseases and have generated antimicrobial resistances that reduce their effectiveness. Following the rationale behind the new paradigm of personalized m...

    Authors: F. Antoñanzas, C. A. Juárez-Castelló and R. Rodríguez-Ibeas
    Citation: Health Economics Review 2021 11:29
  31. This study evaluates the Ahead Of The Game (AOTG) mental health promotion strategy for adolescent males relative to usual practice in team based sporting club community settings, allowing for joint incremental...

    Authors: Simon Eckermann, Nikki McCaffrey, Utsana Tonmukayakul, Christian Swann and Stewart Vella
    Citation: Health Economics Review 2021 11:28
  32. Cost sharing, including copayment and coinsurance, is often used to contain medical expenditure by decreasing unnecessary or excessive use of healthcare resources. Previous studies in Japan have reported the e...

    Authors: Takumi Nishi, Toshiki Maeda, Susumu Katsuki and Akira Babazono
    Citation: Health Economics Review 2021 11:24
  33. Value-based healthcare is being extensively piloted, scaled and implemented by healthcare providers and systems around the world. However, the ability of the healthcare supply chain function to strategically c...

    Authors: Benedict Stanberry, Gerhard Bothma and Katie Harrison
    Citation: Health Economics Review 2021 11:23
  34. This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice.

    Authors: Irfan Cicin, Ergun Oksuz, Nuri Karadurmus, Simten Malhan, Mahmut Gumus, Ulku Yilmaz, Levent Cansever, Halit Cinarka, Erdogan Cetinkaya, Murat Kiyik and Ahmet Ozet
    Citation: Health Economics Review 2021 11:22

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.7
    5-year Journal Impact Factor: 2.8
    Source Normalized Impact per Paper (SNIP): 1.218
    SCImago Journal Rank (SJR): 0.800

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 220

    Usage 2023
    Downloads: 566,888
    Altmetric mentions: 483